Beta-Lactam Infusion in Severe Sepsis (BLISS): a prospective, two-centre, open-labelled randomised controlled trial of continuous versus intermittent beta-lactam infusion in critically ill patients with severe sepsis

A Multicenter Randomized Trial of Continuous versus Intermittent β-Lactam Infusion in Severe Sepsis

(2015) Joel M. Dulhunty et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Comparison of different equations to assess glomerular filtration in critically ill patients

(2015) Mieke Carlier et al.   INTENSIVE CARE MEDICINE

Pharmacokinetics of piperacillin in critically ill patients receiving continuous venovenous haemofiltration: A randomised controlled trial of continuous infusion versus intermittent bolus administration

(2015) Janattul-Ain Jamal et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Pharmacokinetics of meropenem in critically ill patients receiving continuous venovenous haemofiltration: A randomised controlled trial of continuous infusion versus intermittent bolus administration

(2015) Janattul-Ain Jamal et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Is prolonged infusion of piperacillin/tazobactam and meropenem in critically ill patients associated with improved pharmacokinetic/pharmacodynamic and patient outcomes? An observation from the Defining Antibiotic Levels in Intensive care unit patients (DALI) cohort

(2015) Mohd H. Abdul-Aziz et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Applying Pharmacokinetic/Pharmacodynamic Principles in Critically Ill Patients: Optimizing Efficacy and Reducing Resistance Development

(2015) Mohd Abdul-Aziz et al.   SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE

DALI: Defining Antibiotic Levels in Intensive Care Unit Patients: Are Current  -Lactam Antibiotic Doses Sufficient for Critically Ill Patients?

(2014) J. A. Roberts et al.   CLINICAL INFECTIOUS DISEASES

Risk factors for target non-attainment during empirical treatment with β-lactam antibiotics in critically ill patients

(2014) Jan J. De Waele et al.   INTENSIVE CARE MEDICINE

A PROspective study on the Usage patterns of Doripenem in the Asia-Pacific region (PROUD study)

(2014) Mahiran Mustafa et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions

(2014) Jason A Roberts et al.   LANCET INFECTIOUS DISEASES

Standard Versus Prolonged Doripenem Infusion for Treatment of Gram-Negative Infections

(2013) Lama Hsaiky et al.   ANNALS OF PHARMACOTHERAPY

Extended-Infusion Cefepime Reduces Mortality in Patients with Pseudomonas aeruginosa Infections

(2013) Karri A. Bauer et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Protein Binding of β-Lactam Antibiotics in Critically Ill Patients: Can We Successfully Predict Unbound Concentrations?

(2013) Gloria Wong et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Surviving Sepsis Campaign

(2013) R. Phillip Dellinger et al.   CRITICAL CARE MEDICINE

Continuous Infusion of Beta-Lactam Antibiotics in Severe Sepsis: A Multicenter Double-Blind, Randomized Controlled Trial

(2012) J. M. Dulhunty et al.   CLINICAL INFECTIOUS DISEASES

Comparative in vitro activity of carbapenems against major Gram-negative pathogens: results of Asia-Pacific surveillance from the COMPACT II study

(2012) Pattarachai Kiratisin et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Continuous beta-lactam infusion in critically ill patients: the clinical evidence

(2012) Mohd H Abdul-Aziz et al.   Annals of Intensive Care

Analysis of 12 beta-lactam antibiotics in human plasma by HPLC with ultraviolet detection

(2010) Brett C. McWhinney et al.   JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES

A systematic review on clinical benefits of continuous administration of β-lactam antibiotics*

(2009) Jason A. Roberts et al.   CRITICAL CARE MEDICINE

Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T>MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections

(2008) Peggy S. McKinnon et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS